Company Filing History:
4 out of 4 
4 out of 3,381 
Years Active: 2019-2025
Title: Innovations by Inventor John K. Freshley
Introduction
John K. Freshley, an innovative inventor based in Ann Arbor, Michigan, has made significant contributions to the field of biotechnology. With a total of three patents to his name, his work primarily focuses on peptide compositions aimed at protecting retinal cells. His breakthrough inventions reflect a commitment to advancing medical knowledge and technology in vision preservation.
Latest Patents
Among his latest inventions, John K. Freshley has developed peptide compositions and methods of use designed to prevent photoreceptor death. These compositions, which include pharmaceutical preparations, aim to protect retinal cells, including photoreceptors and retinal pigment epithelium, from Fas- or TRAIL-mediated apoptosis. This innovative approach highlights the potential for new treatments in preventing retinal diseases and enhancing visual health.
Career Highlights
Throughout his career, John has worked with notable organizations, including Onl Therapeutics, Inc. and the University of Michigan. His affiliation with these esteemed institutions has allowed him to collaborate with leading researchers and develop his innovative ideas further. The combination of his academic and industry experience has positioned Freshley as a prominent figure in his field.
Collaborations
John K. Freshley has worked alongside talented colleagues, such as Cagri Giray Besirli and Alexander James Bridges. These collaborations have enriched his research experience and nurtured a dynamic exchange of ideas, ultimately contributing to his patent achievements. The synergy among these professionals reflects the importance of teamwork in the advancement of science and technology.
Conclusion
In conclusion, John K. Freshley's contributions to the field of biotechnology through his patent innovations are noteworthy. His work on peptide compositions and methods for protecting retinal cells demonstrates a clear dedication to developing solutions that may significantly impact vision health. As he continues to build on his research, the potential for further advancements remains promising.